Elgix 150 Tablet 10

ELGIX 150 TABLET 10 may interact with the following medicines:

• Antihypertensive medicines (e.g., amlodipine, atenolol): Some patients may experience dizziness or weakness during treatment, which may worsen low blood pressure symptoms in individuals taking antihypertensive medicines. Your doctor may monitor symptoms if needed.
• Antidiabetic medicines (e.g., insulin, metformin): Hormonal changes and appetite changes during treatment may occasionally affect blood sugar control in some individuals. Your doctor may advise blood glucose monitoring if required.
• Antitubercular medicines (e.g., rifampicin, rifabutin): These medicines may reduce elagolix levels in the body and decrease treatment effectiveness. Your doctor may avoid prolonged combined use or monitor treatment response carefully.
• Antiepileptic medicines (e.g., carbamazepine, phenytoin): These medicines may increase the breakdown of elagolix and reduce its effectiveness. Your doctor may monitor symptom control during combined therapy.
• Cardiac glycosides (e.g., digoxin, digitoxin): Elagolix may increase digoxin levels in the body and raise the risk of digoxin-related toxicity. Your doctor may monitor digoxin levels and related symptoms during treatment.
• Hormonal contraceptives (e.g., ethinyl estradiol, levonorgestrel): Hormonal contraceptives may reduce the effectiveness of ELGIX 150 TABLET 10, and this medicine may also affect contraceptive effectiveness. Non-hormonal contraception is generally recommended during treatment and for some time after stopping therapy.

ELGIX 150 TABLET 10 may interact with the following:

• Grapefruit and grapefruit juice: Grapefruit products may increase elagolix levels in the body and increase the risk of side effects. Avoid excessive grapefruit intake during treatment.

ELGIX 150 TABLET 10 should be used with caution if you have:

• Osteoporosis or low bone density: This medicine may reduce bone mineral density, especially with prolonged use. Patients with osteoporosis may have an increased risk of fractures during treatment.
• Mood disorders: Patients with anxiety or previous mood disorders may experience worsening mood changes, emotional symptoms, or suicidal thoughts during treatment. Your doctor may monitor your mental health closely during therapy.
• History of fractures or bone weakness: Long-term treatment may increase the risk of bone-related complications in susceptible individuals. Your doctor may assess bone health before and during therapy.

Take ELGIX 150 TABLET 10 exactly as prescribed by your doctor. The dosage and duration of treatment may vary depending on the severity of endometriosis symptoms, response to treatment, liver function, and overall medical condition. Do not change the prescribed schedule or stop treatment without consulting your doctor.

Taking more than the prescribed amount of ELGIX 150 TABLET 10 may increase the risk of severe nausea, dizziness, mood changes, headache, or hormonal side effects. Seek immediate medical attention if overdose is suspected.

If you miss a dose of ELGIX 150 TABLET 10, take it on the same day as soon as you remember and then continue your regular dosing schedule. Do not take extra doses to compensate for the missed dose.